RightFit Trial Directory

Hypertension clinical trials in Kansas City, KS

13 recruiting hypertension studies with a site in Kansas City, KS.

All trials in Kansas City, KS · All Hypertension trials

RecruitingPhase 3NCT07181109

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Sponsor: Alnylam Pharmaceuticals

Hutchinson, KS · Kansas City, KS · Topeka, KS · +270 more sites

RecruitingPhase 3NCT07179380

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Sponsor: Insmed Incorporated

Kansas City, KS · +18 more sites

RecruitingPhase 2NCT07175038

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

Sponsor: AllRock Bio, Inc.

Kansas City, KS · +10 more sites

RecruitingPhase 3NCT06742723

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

Sponsor: AstraZeneca

Hutchinson, KS · Kansas City, KS · Wichita, KS · +130 more sites

RecruitingPhase 2NCT07333183

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Sponsor: Pulmovant, Inc.

Kansas City, KS · +12 more sites

RecruitingPhase not listedNCT06388421

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Sponsor: United Therapeutics

Kansas City, KS · +69 more sites

RecruitingPhase not listedNCT04278404

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Sponsor: Duke University

Kansas City, KS · +49 more sites

RecruitingPhase 1 / Phase 2NCT06649110

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

Sponsor: Novartis Pharmaceuticals

Kansas City, KS · +19 more sites

RecruitingPhase 1NCT04624490

Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

Sponsor: Mario Castro, MD, MPH

Kansas City, KS

RecruitingNot applicableNCT05889650

External Lumbar Drainage to Reduce ICP in Severe TBI: a Phase 1 Clinical Trial

Sponsor: Brain Trauma Foundation

Kansas City, KS · +5 more sites

RecruitingPhase not listedNCT04808596

Pulmonary Hypertension Biorepository and Registry

Sponsor: University of Kansas Medical Center

Kansas City, KS

RecruitingEarly Phase 1NCT04832009

Reversing Glucose and Lipid-mediated Vascular Dysfunction

Sponsor: University of Kansas Medical Center

Kansas City, KS

RecruitingPhase not listedNCT06626113

Transduction of Sympathetic Neural Activity in Human Obesity Without Hypertension

Sponsor: University of Kansas Medical Center

Kansas City, KS

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.